Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 47 | $33,793,815 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 31 Mar 2025 10:47 | LH | LABCORP HOLDINGS Inc | SUMMY AMY B. | EVP, Chief Marketing Officer | 28 Mar 2025 | Sale | 758 | 231.67 | 175,606 | D |
| 31 Mar 2025 10:39 | LH | LABCORP HOLDINGS Inc | SCHROEDER MARK S | EVP, Pres Diagnostics & COO | 28 Mar 2025 | Sale | 2,635 | 231.67 | 610,450 | D |
| 07 Mar 2025 08:16 | LH | LABCORP HOLDINGS Inc | ANDERSON KERRII B | Director | 05 Mar 2025 | Sale | 500 | 255.6347 | 127,817 | D |
| 04 Mar 2025 08:41 | LH | LABCORP HOLDINGS Inc | SCHROEDER MARK S | EVP, Pres Diagnostics & COO | 28 Feb 2025 | Sale | 5,339 | 249.23 | 1,330,639 | D |
| 27 Feb 2025 10:07 | LH | LABCORP HOLDINGS Inc | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 25 Feb 2025 | Sale | 1,314 | 251.3 | 330,208 | D |
| 26 Feb 2025 09:03 | LH | LABCORP HOLDINGS Inc | SUMMY AMY B. | EVP, Chief Marketing Officer | 24 Feb 2025 | Sale | 226 | 250.4 | 56,590 | D |
| 20 Feb 2025 15:24 | LH | LABCORP HOLDINGS Inc | WILKINSON PETER J | SVP, Chief Accounting Officer | 18 Feb 2025 | Sale | 1,413 | 246.0997 | 347,739 | D |
| 13 Feb 2025 11:49 | LH | LABCORP HOLDINGS Inc | SCHECHTER ADAM H | President & CEO | 11 Feb 2025 | Sale | 6,121 | 244.62 | 1,497,319 | D |
| 08 Jan 2025 11:15 | LH | LABCORP HOLDINGS Inc | ANDERSON KERRII B | Director | 07 Jan 2025 | Sale | 1,000 | 235 | 235,000 | D |
| 04 Dec 2024 09:59 | LH | LABCORP HOLDINGS Inc | EISENBERG GLENN A | Executive Vice President | 02 Dec 2024 | Sale | 11,711 | 240.4279 | 2,815,651 | D |
| 04 Dec 2024 09:55 | LH | LABCORP HOLDINGS Inc | GILLILAND DWIGHT GARY | Director | 02 Dec 2024 | Sale | 1,000 | 241 | 241,000 | D |
| 26 Nov 2024 11:06 | LH | LABCORP HOLDINGS Inc | SUMMY AMY B. | EVP, Chief Marketing Officer | 22 Nov 2024 | Sale | 3,671.5 | 238.9055 | 877,142 | D |
| 25 Nov 2024 08:14 | LH | LABCORP HOLDINGS Inc | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 21 Nov 2024 | Sale | 1,000 | 239.4187 | 239,419 | D |
| 13 Nov 2024 08:16 | LH | LABCORP HOLDINGS Inc | SCHECHTER ADAM H | President & CEO | 11 Nov 2024 | Sale | 6,189 | 243.47 | 1,506,836 | D |
| 25 Oct 2024 09:26 | LH | LABCORP HOLDINGS Inc | ANDERSON KERRII B | Director | 24 Oct 2024 | Sale | 1,000 | 230 | 230,000 | D |
| 21 Aug 2024 09:08 | LH | LABCORP HOLDINGS Inc | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 19 Aug 2024 | Sale | 2,000 | 227.05 | 454,100 | D |
| 19 Aug 2024 10:22 | LH | LABCORP HOLDINGS Inc | EISENBERG GLENN A | Chief Financial Officer, EVP | 15 Aug 2024 | Sale | 9,071 | 224.5488 | 2,036,882 | D |
| 19 Aug 2024 10:22 | LH | LABCORP HOLDINGS Inc | EISENBERG GLENN A | Chief Financial Officer, EVP | 15 Aug 2024 | Sale | 2,950 | 223.6169 | 659,670 | D |
| 19 Aug 2024 10:22 | LH | LABCORP HOLDINGS Inc | EISENBERG GLENN A | Chief Financial Officer, EVP | 15 Aug 2024 | Sale | 2,979 | 222.6494 | 663,273 | D |
| 09 Aug 2024 10:16 | LH | LABCORP HOLDINGS Inc | ANDERSON KERRII B | Director | 07 Aug 2024 | Sale | 414 | 225 | 93,150 | D |
| 09 Aug 2024 10:16 | LH | LABCORP HOLDINGS Inc | ANDERSON KERRII B | Director | 08 Aug 2024 | Sale | 586 | 225 | 131,850 | D |
| 07 Aug 2024 08:47 | LH | LABCORP HOLDINGS Inc | BERBERIAN LANCE | EVP, CIO & CTO | 05 Aug 2024 | Sale | 9,848 | 228.9485 | 2,254,685 | D |
| 07 Aug 2024 08:47 | LH | LABCORP HOLDINGS Inc | BERBERIAN LANCE | EVP, CIO & CTO | 05 Aug 2024 | Sale | 2,245 | 229.785 | 515,867 | D |
| 16 May 2024 08:02 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 14 May 2024 | Sale | 200 | 210.835 | 42,167 | D |
| 16 May 2024 08:02 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 14 May 2024 | Sale | 1,800 | 210.8268 | 379,488 | D |
| 02 May 2024 16:29 | LH | LABORATORY CORP OF AMERICA HOLDINGS | ANDERSON KERRII B | Director | 02 May 2024 | Sale | 250 | 200.0981 | 50,025 | D |
| 02 May 2024 16:29 | LH | LABORATORY CORP OF AMERICA HOLDINGS | ANDERSON KERRII B | Director | 30 Apr 2024 | Sale | 250 | 204.135 | 51,034 | D |
| 01 May 2024 18:29 | LH | LABORATORY CORP OF AMERICA HOLDINGS | WILKINSON PETER J | SVP, Chief Accounting Officer | 29 Apr 2024 | Sale | 2,439 | 204.329 | 498,358 | D |
| 03 Apr 2024 08:35 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SCHROEDER MARK S | EVP, Pres Diagnostics & COO | 01 Apr 2024 | Sale | 6,477 | 217.29 | 1,407,387 | D |
| 03 Apr 2024 08:34 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SUMMY AMY B. | EVP, Chief Marketing Officer | 01 Apr 2024 | Sale | 3,500 | 217.29 | 760,515 | D |
| 29 Mar 2024 17:54 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 28 Mar 2024 | Sale | 3,553 | 216.74 | 770,077 | D |
| 11 Mar 2024 08:59 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SCHROEDER MARK S | EVP, Pres Diagnostics & COO | 07 Mar 2024 | Sale | 5,048 | 218.45 | 1,102,736 | D |
| 11 Mar 2024 08:56 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SUMMY AMY B. | EVP, Chief Marketing Officer | 07 Mar 2024 | Sale | 227 | 218.45 | 49,588 | D |
| 22 Feb 2024 15:05 | LH | LABORATORY CORP OF AMERICA HOLDINGS | EISENBERG GLENN A | Chief Financial Officer, EVP | 21 Feb 2024 | Sale | 1,553 | 217.9842 | 338,529 | D |
| 22 Feb 2024 15:05 | LH | LABORATORY CORP OF AMERICA HOLDINGS | EISENBERG GLENN A | Chief Financial Officer, EVP | 21 Feb 2024 | Sale | 6,665 | 217.5205 | 1,449,774 | D |
| 22 Feb 2024 15:05 | LH | LABORATORY CORP OF AMERICA HOLDINGS | EISENBERG GLENN A | Chief Financial Officer, EVP | 21 Feb 2024 | Sale | 7,907 | 215.6759 | 1,705,349 | D |
| 22 Feb 2024 15:05 | LH | LABORATORY CORP OF AMERICA HOLDINGS | EISENBERG GLENN A | Chief Financial Officer, EVP | 21 Feb 2024 | Sale | 18,379 | 215.3661 | 3,958,214 | D |
| 22 Feb 2024 15:04 | LH | LABORATORY CORP OF AMERICA HOLDINGS | DIVINCENZO JONATHAN P. | EVP, Pres, Central Labs & Intl | 21 Feb 2024 | Sale | 500 | 215.4901 | 107,745 | D |
| 15 Feb 2024 08:32 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 13 Feb 2024 | Sale | 237 | 226.45 | 53,669 | D |
| 09 Feb 2024 12:19 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 08 Feb 2024 | Sale | 259 | 222.06 | 57,514 | D |
| 06 Feb 2024 15:47 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 05 Feb 2024 | Sale | 193 | 220.57 | 42,570 | D |
| 20 Nov 2023 12:23 | LH | LABORATORY CORP OF AMERICA HOLDINGS | WILKINSON PETER J | SVP, Chief Accounting Officer | 16 Nov 2023 | Sale | 1,384 | 210.713 | 291,627 | D |
| 10 Aug 2023 08:55 | LH | LABORATORY CORP OF AMERICA HOLDINGS | ANDERSON KERRII B | Director | 08 Aug 2023 | Sale | 5,000 | 211.5665 | 1,057,832 | D |
| 03 Jul 2023 11:52 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 29 Jun 2023 | Sale | 212 | 240 | 50,880 | D |
| 23 May 2023 08:06 | LH | LABORATORY CORP OF AMERICA HOLDINGS | KIRCHGRABER PAUL R | CEO, Covance Drug Development | 19 May 2023 | Sale | 4,300 | 216.9086 | 932,707 | D |
| 22 May 2023 15:08 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SCHROEDER MARK S | EVP, Pres Diagnostics & COO | 18 May 2023 | Sale | 1,500 | 216.77 | 325,155 | D |
| 03 Apr 2023 10:05 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SCHROEDER MARK S | EVP, President-Diagnostics Lab | 31 Mar 2023 | Sale | 3,897 | 225.81 | 879,982 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)